Literature DB >> 24436667

Perioperative Beta blockade.

Jennifer Lynn Irani1.   

Abstract

The use of preoperative beta (β) blockade has been through several changes, and it is clear that large, randomized controlled trials on the subject are in need. Currently, a judicious approach to perioperative β blockade is supported. Continuation of β blockers is recommended for the patient taking them prior to surgery. Patients undergoing large colorectal procedures, with coronary artery disease or high cardiac risk, should have β blockers titrated to heart rate and blood pressure. Dosages should be titrated to heart rate and blood pressure rather than using fixed, long-acting dosages. When β blockers are indicated, they should be initiated weeks before surgery.

Entities:  

Keywords:  colon and rectal surgery; coronary artery disease; perioperative; β blockers

Year:  2013        PMID: 24436667      PMCID: PMC3747283          DOI: 10.1055/s-0033-1351131

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  12 in total

1.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

Authors:  T H Lee; E R Marcantonio; C M Mangione; E J Thomas; C A Polanczyk; E F Cook; D J Sugarbaker; M C Donaldson; R Poss; K K Ho; L E Ludwig; A Pedan; L Goldman
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index.

Authors:  Eric Boersma; Miklos D Kertai; Olaf Schouten; Jeroen J Bax; Peter Noordzij; Ewout W Steyerberg; Arend F L Schinkel; Marian van Santen; Maarten L Simoons; Ian R Thomson; Jan Klein; Hero van Urk; Don Poldermans
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

Review 3.  2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliot L Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

4.  2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliot L Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

5.  2009 ACCF/AHA focused update on perioperative beta blockade: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.

Authors:  Kirsten E Fleischmann; Joshua A Beckman; Christopher E Buller; Hugh Calkins; Lee A Fleisher; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; John F Robb; R James Valentine
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

Review 6.  beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review.

Authors:  Andrew D Auerbach; Lee Goldman
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

7.  Lessons learned from the institution of the Surgical Care Improvement Project at a teaching medical center.

Authors:  Bruce Potenza; Michelle Deligencia; Brenda Estigoy; Eema Faraday; Andrea Snyder; Niren Angle; Alexandra Schwartz; Leon Chang; James Hackett; Anushirvan Minokadeh; Michael Madani; Kathryn MacAulay; Sonia Ramamoorthy; Lynn Blaner; Charles James; Vishal Bansal; Francesca Torriani; Raul Coimbra
Journal:  Am J Surg       Date:  2009-12       Impact factor: 2.565

Review 8.  Perioperative beta-blockers for major noncardiac surgery: Primum Non Nocere.

Authors:  Vineet Chopra; Benjamin Plaisance; Erdal Cavusoglu; Scott A Flanders; Kim A Eagle
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

9.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.

Authors:  P J Devereaux; Homer Yang; Salim Yusuf; Gordon Guyatt; Kate Leslie; Juan Carlos Villar; Denis Xavier; Susan Chrolavicius; Launi Greenspan; Janice Pogue; Prem Pais; Lisheng Liu; Shouchun Xu; German Málaga; Alvaro Avezum; Matthew Chan; Victor M Montori; Mike Jacka; Peter Choi
Journal:  Lancet       Date:  2008-05-12       Impact factor: 79.321

10.  Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).

Authors:  Martin Dunkelgrun; Eric Boersma; Olaf Schouten; Ankie W M M Koopman-van Gemert; Frans van Poorten; Jeroen J Bax; Ian R Thomson; Don Poldermans
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.